-
Mashup Score: 0HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Did you know that most patients w/ lung cancer receive diagnoses of advanced disease & face poor survival outcomes? This satellite symposium will offer ways to improve outcomes for your patients w/ lung cancer. Register: https://t.co/UTxUGfJaKb #gotoPER #NSCLC #lcsm #THORACIC21 https://t.co/y878Oc7ZZd
-
-
Mashup Score: 1HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HOME - NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings - 3 year(s) ago
NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Discover the 2021 symposium program including abstracts, schedule of events, and continuing education credits.
Source: www.astro.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
There’s still time to register and earn complimentary CME/CE credits for this satellite symposium on December 1. Secure your spot now: https://t.co/IDNpINLjD2 #gotoPER #NSCLC #lcsm #THORACIC21 https://t.co/BoqtqtGkjE